Cargando…

Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil

OBJECTIVE: To determine whether mobility therapy is associated with central or peripheral catheter-related adverse events in critically ill patients in an ICU in Brazil. METHODS: A retrospective analysis of the daily medical records of patients admitted to the Clinical Emergency ICU of the Universit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lima, Natália Pontes, da Silva, Gregório Marques Cardim, Park, Marcelo, Pires-Neto, Ruy Camargo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541757/
https://www.ncbi.nlm.nih.gov/pubmed/26176520
http://dx.doi.org/10.1590/S1806-37132015000004338
_version_ 1782386430215979008
author Lima, Natália Pontes
da Silva, Gregório Marques Cardim
Park, Marcelo
Pires-Neto, Ruy Camargo
author_facet Lima, Natália Pontes
da Silva, Gregório Marques Cardim
Park, Marcelo
Pires-Neto, Ruy Camargo
author_sort Lima, Natália Pontes
collection PubMed
description OBJECTIVE: To determine whether mobility therapy is associated with central or peripheral catheter-related adverse events in critically ill patients in an ICU in Brazil. METHODS: A retrospective analysis of the daily medical records of patients admitted to the Clinical Emergency ICU of the University of São Paulo School of Medicine Hospital das Clínicas Central Institute between December of 2009 and April of 2011. In addition to the demographic and clinical characteristics of the patients, we collected data related to central venous catheters (CVCs), hemodialysis (HD) catheters and indwelling arterial catheters (IACs): insertion site; number of catheter days; and types of adverse events. We also characterized the mobility therapy provided. RESULTS: Among the 275 patients evaluated, CVCs were used in 49%, HD catheters were used in 26%, and IACs were used in 29%. A total of 1,268 mobility therapy sessions were provided to patients while they had a catheter in place. Catheter-related adverse events occurred in 20 patients (a total of 22 adverse events): 32%, infection; 32%, obstruction; and 32%, accidental dislodgement. We found that mobility therapy was not significantly associated with any catheter-related adverse event, regardless of the type of catheter employed: CVC-OR = 0.8; 95% CI: 0.7-1.0; p = 0.14; HD catheter-OR = 1.04; 95% CI: 0.89-1.21; p = 0.56; or IAC-OR = 1.74; 95% CI: 0.94-3.23; p = 0.07. CONCLUSIONS: In critically ill patients, mobility therapy is not associated with the incidence of adverse events involving CVCs, HD catheters, or IACs.
format Online
Article
Text
id pubmed-4541757
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-45417572015-08-28 Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil Lima, Natália Pontes da Silva, Gregório Marques Cardim Park, Marcelo Pires-Neto, Ruy Camargo J Bras Pneumol Original Articles OBJECTIVE: To determine whether mobility therapy is associated with central or peripheral catheter-related adverse events in critically ill patients in an ICU in Brazil. METHODS: A retrospective analysis of the daily medical records of patients admitted to the Clinical Emergency ICU of the University of São Paulo School of Medicine Hospital das Clínicas Central Institute between December of 2009 and April of 2011. In addition to the demographic and clinical characteristics of the patients, we collected data related to central venous catheters (CVCs), hemodialysis (HD) catheters and indwelling arterial catheters (IACs): insertion site; number of catheter days; and types of adverse events. We also characterized the mobility therapy provided. RESULTS: Among the 275 patients evaluated, CVCs were used in 49%, HD catheters were used in 26%, and IACs were used in 29%. A total of 1,268 mobility therapy sessions were provided to patients while they had a catheter in place. Catheter-related adverse events occurred in 20 patients (a total of 22 adverse events): 32%, infection; 32%, obstruction; and 32%, accidental dislodgement. We found that mobility therapy was not significantly associated with any catheter-related adverse event, regardless of the type of catheter employed: CVC-OR = 0.8; 95% CI: 0.7-1.0; p = 0.14; HD catheter-OR = 1.04; 95% CI: 0.89-1.21; p = 0.56; or IAC-OR = 1.74; 95% CI: 0.94-3.23; p = 0.07. CONCLUSIONS: In critically ill patients, mobility therapy is not associated with the incidence of adverse events involving CVCs, HD catheters, or IACs. Sociedade Brasileira de Pneumologia e Tisiologia 2015 /pmc/articles/PMC4541757/ /pubmed/26176520 http://dx.doi.org/10.1590/S1806-37132015000004338 Text en http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lima, Natália Pontes
da Silva, Gregório Marques Cardim
Park, Marcelo
Pires-Neto, Ruy Camargo
Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil
title Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil
title_full Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil
title_fullStr Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil
title_full_unstemmed Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil
title_short Mobility therapy and central or peripheral catheter-related adverse events in an ICU in Brazil
title_sort mobility therapy and central or peripheral catheter-related adverse events in an icu in brazil
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541757/
https://www.ncbi.nlm.nih.gov/pubmed/26176520
http://dx.doi.org/10.1590/S1806-37132015000004338
work_keys_str_mv AT limanataliapontes mobilitytherapyandcentralorperipheralcatheterrelatedadverseeventsinanicuinbrazil
AT dasilvagregoriomarquescardim mobilitytherapyandcentralorperipheralcatheterrelatedadverseeventsinanicuinbrazil
AT parkmarcelo mobilitytherapyandcentralorperipheralcatheterrelatedadverseeventsinanicuinbrazil
AT piresnetoruycamargo mobilitytherapyandcentralorperipheralcatheterrelatedadverseeventsinanicuinbrazil